MLTX FY 2022 Earnings — MoonLake Immunotherapeutics Revenue & Financial Results | Market Cap Arena

MLTXMoonLake Immunotherapeutics

$1B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$65M

Net Income

-$50M

EPS (Diluted)

$-2.20

Cash Flow

Operating Cash Flow

-$56M

Free Cash Flow

-$56M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$77M

Total Liabilities

$8M

Stockholders' Equity

$49M

Cash & Equivalents

$40M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$4,971	+100.0%
Operating Income	-$65M	-$54M	-21.4%
Net Income	-$50M	-$54M	+6.8%